Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3459 | 1904 | 49.6 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EPHRIN | Author keyword | 266 | 67% | 13% | 240 |
2 | EPH | Author keyword | 218 | 77% | 8% | 147 |
3 | EPHA2 | Author keyword | 129 | 75% | 5% | 94 |
4 | EPH RECEPTORS | Author keyword | 106 | 81% | 3% | 64 |
5 | EPH RECEPTOR | Author keyword | 102 | 76% | 4% | 71 |
6 | EPHB4 | Author keyword | 96 | 74% | 4% | 70 |
7 | EPHRINS | Author keyword | 69 | 63% | 4% | 70 |
8 | EPHRIN B2 | Author keyword | 44 | 70% | 2% | 37 |
9 | EPHRINA1 | Author keyword | 42 | 94% | 1% | 15 |
10 | EPHRINB2 | Author keyword | 36 | 70% | 2% | 30 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EPHRIN | 266 | 67% | 13% | 240 | Search EPHRIN | Search EPHRIN |
2 | EPH | 218 | 77% | 8% | 147 | Search EPH | Search EPH |
3 | EPHA2 | 129 | 75% | 5% | 94 | Search EPHA2 | Search EPHA2 |
4 | EPH RECEPTORS | 106 | 81% | 3% | 64 | Search EPH+RECEPTORS | Search EPH+RECEPTORS |
5 | EPH RECEPTOR | 102 | 76% | 4% | 71 | Search EPH+RECEPTOR | Search EPH+RECEPTOR |
6 | EPHB4 | 96 | 74% | 4% | 70 | Search EPHB4 | Search EPHB4 |
7 | EPHRINS | 69 | 63% | 4% | 70 | Search EPHRINS | Search EPHRINS |
8 | EPHRIN B2 | 44 | 70% | 2% | 37 | Search EPHRIN+B2 | Search EPHRIN+B2 |
9 | EPHRINA1 | 42 | 94% | 1% | 15 | Search EPHRINA1 | Search EPHRINA1 |
10 | EPHRINB2 | 36 | 70% | 2% | 30 | Search EPHRINB2 | Search EPHRINB2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRANSMEMBRANE LIGANDS | 338 | 87% | 9% | 166 |
2 | EPHRINS | 213 | 78% | 7% | 140 |
3 | EPH RECEPTORS | 129 | 44% | 12% | 225 |
4 | EPHRIN LIGANDS | 69 | 81% | 2% | 42 |
5 | ECK | 64 | 88% | 2% | 30 |
6 | TYROSINE KINASE EPHB4 | 50 | 88% | 1% | 23 |
7 | REGULATES INTEGRIN ACTIVITY | 48 | 91% | 1% | 20 |
8 | RETINAL AXON GUIDANCE | 47 | 68% | 2% | 41 |
9 | NUK | 45 | 94% | 1% | 16 |
10 | A LIGANDS | 41 | 100% | 1% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Therapeutic targeting of EPH receptors and their ligands | 2014 | 31 | 297 | 83% |
Eph-ephrin bidirectional signaling in physiology and disease | 2008 | 474 | 84 | 83% |
Eph receptors and ephrins in cancer: bidirectional signalling and beyond | 2010 | 307 | 223 | 77% |
EPH receptor signalling casts a wide net on cell behaviour | 2005 | 537 | 129 | 84% |
Bidirectional modulation of synaptic functions by Eph/ephrin signaling | 2009 | 201 | 46 | 80% |
Molecular dynamics in drug design | 2015 | 3 | 13 | 38% |
EphB/ephrinB Signaling in Cell Adhesion and Migration | 2015 | 1 | 73 | 86% |
Eph receptors: New players in Alzheimer's disease pathogenesis | 2015 | 2 | 280 | 46% |
Mechanisms and functions of EPH and ephrin signalling | 2002 | 652 | 113 | 78% |
Eph Receptors and Ephrins: Therapeutic Opportunities | 2015 | 1 | 164 | 75% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MICROSCOPY CYTOMETRY | 13 | 80% | 0.4% | 8 |
2 | KENT WALDREP BASIC NERVE GROWTH REGENER | 11 | 54% | 0.7% | 14 |
3 | LEUKAEMIA FDN UNIT | 5 | 60% | 0.3% | 6 |
4 | RAMMELKAMP | 5 | 24% | 0.9% | 17 |
5 | LEUKAEMIA FDN | 4 | 35% | 0.5% | 9 |
6 | CYTOMETRY FLUO CENCE MICROSCOPY | 3 | 57% | 0.2% | 4 |
7 | PEDIATINFECT IMMUN INJURY REPAIR PROGRAM | 3 | 100% | 0.2% | 3 |
8 | KENT WALDREP FDN BASIC NERVE GROWTH REG | 3 | 32% | 0.4% | 8 |
9 | VASC DEV | 3 | 35% | 0.4% | 7 |
10 | ABRCCMRI | 3 | 60% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000067654 | NETRIN//NETRIN 1//ROBO |
2 | 0.0000064495 | RETINAL WAVES//DECUSSATION PATTERN//RETINOTOPIC ORDER |
3 | 0.0000056894 | DELTA LIKE LIGAND 4//DLL4//ARTERIAL VENOUS DIFFERENTIATION |
4 | 0.0000045808 | SEMAPHORIN//PLEXIN//NEUROPILIN |
5 | 0.0000040011 | VASCULOGENIC MIMICRY//TIANJIN CANC HOSP//TEM7 |
6 | 0.0000036639 | ODZ//TEN M//TENEURIN |
7 | 0.0000035887 | RHOMBOMERE//HINDBRAIN//PHARYNGEAL ARCH |
8 | 0.0000032307 | FRONTONASAL DYSPLASIA//PROBOSCIS LATERALIS//CRANIOFRONTONASAL DYSPLASIA |
9 | 0.0000027069 | NOGO A//NOGO//NOGO RECEPTOR |
10 | 0.0000026980 | ACP1//PHOSPHOTYROSINE PROTEIN PHOSPHATASE//LMW PTP |